Leveraging Data with Model-Informed Drug Development (MIDD) for Optimal Study Design and Analysis | Allucent

Home  /  Resources  /  Brochure  /  Model-Informed Drug Development

Model-Informed Drug Development

Model-Informed Drug Development Hero

Let your data be your guide. With model-informed drug development (MIDD), you can leverage your existing data and others to optimize your pre-clinical and clinical studies and development programs. Allucent has an expert team of pharmacometricians and modelers with state-of-the-art high-performance computing (AWS) to help you design, simulate and analyze your drug development studies and programs.

Download the full case study below to learn more.

DOWNLOAD RESOURCE

Author name goes here

Request a Proposal

Featured Content

Understanding ICH E11A Key Features of the Pediatric Extrapolation Guideline and Implications for Sponsors

Blog

ICH E11A: Key Features and Implications of the Pediatric Extrapolation Guideline

Read More

The Expansion of Cell & Gene Therapies into Autoimmune Disease 

Infographic

Shifting Frontiers: The Expansion of Cell & Gene Therapies into Autoimmune Disease 

Read More
Rare Disease Clinical Trials: Challenges, Strategies, and Solutions for Success

Blog

Rare Disease Clinical Trials: Challenges, Strategies, and Solutions for Success

Read More

View All Resources

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Schedule a Consultation

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

View Open Jobs

Subscribe to our monthly newsletter